Tag
Hemo Organic Limited
5 articles
Hemo Organic Limited's financial performance demonstrates a significant turnaround, with Q2 FY27 revenue surging to ₹142.90 lakhs compared to a negligible figure in the prior year, alongside a net profit of ₹0.53 lakh reversing a previous loss. However, the company faces scrutiny as auditors have issued a qualified opinion due to a lack of balance confirmations for trade receivables and payables. Adding to the complexity, promoters Dineshbhai and Sonalben Patel are divesting a substantial 16.38% stake in an off-market transaction, while a planned appointment of a Company Secretary has been withdrawn, potentially introducing uncertainty as the company navigates these transitions.
Hemo Organic Q2 Net Profit ₹0.53 Lakh
Hemo Organic reported Q2 FY27 standalone net profit of ₹0.53 lakh versus a loss of ₹4.12 lakh in Q2 FY26.
The company raised ₹4.25 crore through preferential allotment of 34 lakh convertible warrants
Hemo Organic Q2 FY2026 Revenue Surges to ₹142.90 Lakhs
• Hemo Organic reported Q2 FY2026 standalone revenue of ₹142.90 lakhs, a massive increase from ₹0.01 lakhs in Q2 FY2025.
• The company posted a net profit of ₹0.53 lakhs for the quarter, reversing a l
Hemo Organic Board Meeting on October 17, 2026
Hemo Organic Limited schedules board meeting on October 17, 2026, to review Q2 FY2027 financial results.
Agenda includes consideration and approval of un-audited financial results for quarter ended Se
Hemo Organic Secretary Withdraws Consent Before Appointment
Hemo Organic Ltd intimated BSE that Mrs. Pratibha Sharma withdrew her consent to act as Company Secretary and Compliance Officer before the appointment took effect.
The company confirmed no material r
Hemo Organic Promoters Sell 16.38% Stake
Promoters Dineshbhai and Sonalben Patel agree to sell 567,958 equity shares representing 16.38% of Hemo Organic's paid-up capital.
Four buyers including individuals, an LLP, and a trust will acquire t